Janice Gault presents the fifth edition of the critically acclaimed Ophthalmology Secrets. If you are someone like me, who is sceptical and needs persuaded to add another textbook to their collection, let me be the first to convince you the...
The authors present a pilot randomised placebo controlled double blind trial assessing 20mg fluoxetine once daily for 90 days versus placebo in stroke survivors with isolated homonymous hemianopia. Exclusion criteria were extensive in terms of pre-existing ophthalmic or neurologic disease,...
5 October 2020
| Gwyn Samuel Williams
|
EYE - General
After a week on call grading what feels like 13 billion referrals I decided it might be useful to come up with a glossary that might help other people in some way to decipher the true meaning behind every repetitive...
Australian medical clinics and recruiters are seeing a significant rise in applications and enquiries from UK General Practitioners hoping to move down under. As junior doctors strike for more pay and pressure increases on the NHS, Australia is becoming an...
3 February 2026
| Lizzie Rosen, Priyadarshini Suresh, Harry Rosen
|
EYE - Cataract
Cataract surgery is the most frequently performed surgical procedure in the UK [1]. With financially strained NHS trusts and the rise of independent sector cataract providers, the drive from initiatives like Get It Right First Time (GIRFT) and market pressures...
A survey by eye research charity Fight for Sight has found that people with sight loss fear their sight will further deteriorate during the Covid-19 pandemic, as they struggle to access treatment for their eye conditions.
Sight loss charity the Macular Society has announced a new partnership with OcuPlan, a service designed to give patients with long-term eye conditions such as macular disease affordable access to specialist care to prevent unnecessary sight loss.
Gail Burns, from Edinburgh, ran to fundraise for sight loss charity, RNIB Scotland, who supported her father in his diagnosis of age-related macular degeneration just two years ago.
Optos, Plc, the leading retinal imaging company, announces it is expanding the optomap® ultra-widefield (UWF™) retinal imaging modalities available with the California FA device to further assist eyecare professionals in disease management and treatment planning.
After nearly a decade of dedicated service as chief executive of leading sight loss charity the Macular Society, Cathy Yelf has announced her decision to retire in 2024.